(Q47953579)

English

Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers

scientific article published in August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Iovino M

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

Feifel U

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

Yong CL

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

Wolters JM

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

Wallenstein G

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

24

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

645-656

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

The neurobiology of vascular head pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Migraine--current understanding and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Tolerability of the triptans: clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00726.X

21 January 2018

Identifiers

10.1111/J.1468-2982.2004.00726.X

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15265053

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47953579&oldid=2177058681"